English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Department of Respiratory Medicine, Fujian Medical University Union Hospital, Fuzhou, China; Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, China Contributions: (I) Conception and design: X Chen, S Yang; (II) Administrative support: D Xue; (III) Provision of study materials or patients: D Xue, H Lin, L Lin; (IV) Collection and assembly of data: L Lin, Q Wei; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. These authors contributed equally to this work. Correspondence to: Xiangqi Chen. Department of Respiratory Medicine, Fujian Medical University Union Hospital, Fuzhou 350001, China. Email: xqchenfjmu@126.com; Sheng Yang. Department of Oncology, Fujian Medical University Union Hospital, Fuzhou 350001, China. Email: dryangxh@126.com.

TTN/TP53 mutation might act as the predictor for chemotherapy response in lung adenocarcinoma and lung squamous carcinoma patients